Asset Planning,Inc Exact Sciences Corp Transaction History
Asset Planning,Inc
- $133 Billion
- Q2 2025
A detailed history of Asset Planning,Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Asset Planning,Inc holds 703 shares of EXAS stock, worth $33,420. This represents 0.03% of its overall portfolio holdings.
Number of Shares
703
Previous 703
-0.0%
Holding current value
$33,420
Previous $30.4 Million
22.75%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
638Shares Held
156MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$848 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$838 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$594 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$574 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$314 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.41B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...